ID   KM22
AC   CVCL_WJ11
SY   KM-22
DR   Wikidata; Q94426665
RX   PubMed=12836015;
RX   PubMed=19414332;
RX   PubMed=21965729;
RX   PubMed=22399590;
CC   HLA typing: A*02,32; B*07,27; DQB1*03:01,04:02; DRB1*08:01,11:03 (PubMed=12836015).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
RX   PubMed=12836015; DOI=10.1007/s00432-003-0445-7;
RA   Kayser S., Watermann I., Rentzsch C., Weinschenk T., Wallwiener D.,
RA   Guckel B.;
RT   "Tumor-associated antigen profiling in breast and ovarian cancer:
RT   mRNA, protein or T cell recognition?";
RL   J. Cancer Res. Clin. Oncol. 129:397-409(2003).
//
RX   PubMed=19414332;
RA   Weidle U.H., Evtimova V., Alberti S., Guerra E., Fersis N., Kaul S.;
RT   "Cell growth stimulation by CRASH, an asparaginase-like protein
RT   overexpressed in human tumors and metastatic breast cancers.";
RL   Anticancer Res. 29:951-963(2009).
//
RX   PubMed=21965729;
RA   Eichbaum C., Meyer A.-S., Wang N., Bischofs E., Steinborn A.,
RA   Bruckner T., Brodt P., Sohn C., Eichbaum M.H.R.;
RT   "Breast cancer cell-derived cytokines, macrophages and cell adhesion:
RT   implications for metastasis.";
RL   Anticancer Res. 31:3219-3227(2011).
//
RX   PubMed=22399590;
RA   Bischofs E., Lubs D., Fritzsche F., Meyer A.-S., Bruckner T., Sohn C.,
RA   Eichbaum M.H.R.;
RT   "In vitro blockade of adhesion of breast cancer cells to endothelial
RT   cells using anti-inflammatory drugs.";
RL   Anticancer Res. 32:767-771(2012).
//